跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,316 条关于
“XBB.2.3”
全部
3,316
临床试验
1,832
药物
871
机构
4
资讯
609
2年前
Novavax COVID-19 Vaccine Receives FDA Emergency Use Authorization for 2023-2024 Formula
3年前
FDA Warns Evusheld May Be Ineffective Against COVID-19 Subvariant XBB.1.5
3年前
Moderna Submits FDA Application for Updated COVID-19 Vaccine Targeting XBB Variants
去年
Novel Trivalent COVID-19 Vaccine Shows Robust Cross-Protection Against XBB Variants
上个月
Bristol Myers Squibb Selects Houston for $2.3 Billion Multi-Modal Manufacturing Campus
3年前
FDA Approves Updated COVID-19 Vaccines from Pfizer and Moderna Targeting XBB.1.5 Omicron Variant
去年
Novavax's XBB.1.5-Based COVID-19 Booster Shows Superior Immune Response in Phase 2/3 Trial
去年
TEPEZZA Sales Surge as Thyroid Eye Disease Treatment Market Expands to $2.3 Billion
去年
Italy Appoints Special Commissioner to Fast-Track Novo Nordisk's $2.3 Billion Manufacturing Investment
去年
Cystic Fibrosis Foundation Invests $2.3 Million in Owlstone Medical to Develop Breath-Based Pathogen Test
第 1 页,共 61 页
上一页
下一页